7 completed, 1 terminated. 4 Phase 2, 3 Phase 3, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Not applicable | 2 | Completed 2 |
Follow Graft Occlusion, Vascular: new trials by email Literature Review of Graft Occlusion, Vascular trials Research Report on Graft Occlusion, Vascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hemostatic Endothelial Dysfunction in Patients With Peripheral Artery Disease an arterial reconstructive procedure - Peripheral Artery Disease, Restenosis of Peripheral Vascular Stent | Completed | Ryazan State Medical University | 167 | 2017-01-01 | 2023-05-03 | |
| Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) Conventional angioplasty, Angioplasty with drug-eluting balloon - Vascular Access Complication, Restenosis, Vascular Graft | Not applicable | Completed | Helsinki University Central Hospital | 39 | 2013-01-23 | 2017-06-23 |
| GFR Measurement With Contrast-enhanced Dynamic MRI Contrast-enhanced dynamic MRI - Transplantation, Kidney, Graft Occlusion, Vascular | Not applicable | Completed | University Hospital, Bordeaux | 71 | 2008-01-01 | 2026-05-14 |
| External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access External ionizing radiations - Renal Insufficiency, Chronic, Graft Occlusion, Vascular | Phase 2 / Phase 3 | Terminated | University Hospital, Bordeaux | 5 | 2006-12-01 | 2015-03-18 |
| Total Laparoscopic Versus Open Aortic Surgery for Abdominal Aortic Disease Aortic repair - Graft Occlusion, Vascular | Completed | University of Poitiers | 228 | 2006-01-01 | 2014-12-25 | |
| A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis PEG-hirudin - Chronic Kidney Failure, Vascular Graft Occlusion | Phase 2 | Completed | Speedel Pharma Ltd. | 260 | 2003-11-01 | 2007-10-05 |
| Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures CGT003 (E2F Duplex Decoy) - Peripheral Vascular Diseases, Arterial Occlusive Diseases | Phase 2 / Phase 3 | Completed | Anesiva, Inc. | 1400 | 2001-11-01 | 2005-07-15 |
| A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels. BO-653 - Graft Occlusion, Vascular, Coronary Restenosis | Phase 2 / Phase 3 | Completed | Chugai Pharma USA | 2005-06-24 |
Atherosclerosis (2) · Thrombosis (2) · Arterial Occlusive Diseases (1) · Coronary Restenosis (1) · Hyperplasia (1) · Ischemia (1) · Kidney Failure, Chronic (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1) · Renal Insufficiency, Chronic (1)
Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Postoperative Complications (8) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Arteriosclerosis (3) · Arterial Occlusive Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Embolism and Thrombosis (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Renal Insufficiency (2)
2,3-dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran (1) · Angioplasty (1) · Dynamic Contrast Enhanced Magnetic Resonance Imaging (1) · Endovascular Aneurysm Repair (1) · polyethyleneglycol-hirudin (1)
University Hospital, Bordeaux (2) · Anesiva, Inc. (1) · Chugai Pharma USA (1) · Helsinki University Central Hospital (1) · Ryazan State Medical University (1) · Speedel Pharma Ltd. (1) · University of Poitiers (1)
United States (3) · France (2) · Canada (1)
Jean-Baptiste Ricco, MD, PhD (1) · Jessica M Mann, MD, PhD (1) · Maarit Venermo, Prof (1) · Nina Mzhavanadze, MD, PhD (1) · Paul Perez, Dr (1) · Todd Lorenz, M.D. (1)
PMID 27102201, PMID 28644602, PMID 30113592, PMID 30182815, PMID 31221527, PMID 34349046